Form 4: Bausch Health CFO Jean-Jacques Charhon Reports Changes in Beneficial Ownership

EVP and CFO of Bausch Health Companies Inc., Jean-Jacques Charhon, reports acquisition and disposal of common shares and restricted share units.

Summary

• Jean-Jacques Charhon, EVP and CFO of Bausch Health Companies Inc., filed a Form 4 detailing changes in beneficial ownership.
• On February 26, 2025, Charhon acquired 216,622 common shares at $0 and disposed of 515,460 shares.
• Following these transactions, Charhon beneficially owns 515,460 common shares.
• The filing also reports the award of restricted share units (RSUs) that vest in three equal installments on the anniversaries of the grant date, contingent upon continued service.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing represents routine transactions. The acquisition could be seen as positive, but the disposal tempers this view.

Positives

• The acquisition of shares could be interpreted as a sign of confidence in the company's future prospects by the CFO.

Negatives

• The disposal of a large number of shares by the CFO could raise concerns among investors.

Risks

• Significant stock transactions by company executives can sometimes create uncertainty in the market.

Future Outlook

The vesting of RSUs over the next three years is contingent upon the reporting person's continued service.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. Investors often monitor these filings to gauge executive sentiment and potential future performance.

Comparison to Industry Standards

• Monitoring insider transactions is a common practice in the investment community.
• Comparing the volume and frequency of insider trading activity at Bausch Health to peers like Teva Pharmaceuticals or Allergan (now part of AbbVie) can provide context.
• For example, if other pharmaceutical companies' executives are also acquiring shares, it could signal a positive industry outlook.

Stakeholder Impact

• Shareholders may react to the reported transactions, potentially influencing the stock price.
• Employees may view the RSU grants as a positive incentive.

Key Dates